. Scientific Frontline: Why Ebola Virus Triggers Deadly Inflammation in Humans

Friday, November 20, 2026

Why Ebola Virus Triggers Deadly Inflammation in Humans

Ebola virus forms membraneless condensates (yellow) during infection.
Ebola virus forms membraneless condensates (yellow) during infection.
Image Credit: Courtesy of La Jolla Institute for Immunology

Scientific Frontline: Extended "At a Glance" Summary
: Species-Dependent Host mRNA Sequestration in Ebola Virus Condensates

The Core Concept: Researchers led by the La Jolla Institute for Immunology (LJI), in collaboration with Princeton University and the University of California, San Diego, discovered that Ebola virus traps specific human messenger RNA (mRNA) molecules inside membraneless viral condensates, disrupting the clearance of innate immune signals and triggering fatal hyperinflammation. Because comparable antiviral mRNAs in bats fold differently and largely evade capture within these viral compartments, bats keep Ebola virus infection in check without developing the severe inflammatory pathology seen in humans.

Key Distinction/Mechanism: Upon entering a host cell, Ebola virus forms phase-separated, bubble-like compartments called membraneless viral condensates (or viral factories) to concentrate viral building blocks and produce progeny. Using spatial transcriptomics and structural analyses, the team found that specific RNA folding features cause human mRNAs encoding type I interferon (IFN) response pathways and interferon-stimulated genes (ISGs) to partition selectively into these viral condensates. Once sequestered inside the condensates, these potent antiviral transcripts are shielded from normal cellular degradation, keeping cytokine production switched on and driving runaway tissue damage, organ failure, and death—whereas differently folded defense mRNAs in Egyptian fruit bats resist recruitment, degrade on schedule, and keep harmful inflammation under control.

Origin/History: Illnesses caused by Ebola virus and its relatives carry an approximately 50% fatality rate in humans, with the ongoing outbreak in the Democratic Republic of Congo exceeding 10,500 confirmed cases and 5,130 deaths according to the US Centers for Disease Control and Prevention. Explaining why fatal human cases feature paradoxical, overwhelming inflammatory responses—whereas bat hosts such as Egyptian fruit bats, a known reservoir species for the related Marburg virus, harbor infection without symptoms—has remained a major puzzle in immunology and virology.

Major Frameworks/Components:

  • Membraneless Viral Condensates: Inside infected host cells, Ebola virus physically condenses viral material into distinct, bubble-like compartments ("viral factories" or "nests") that enrich viral components for replication while pulling in surrounding host cellular mRNAs.
  • Spatial Transcriptomics and RNA Folding: Combining spatial transcriptomics with structural biology revealed that subtle structural folding differences in cellular mRNAs determine whether host transcripts are selectively recruited into Ebola virus condensates.
  • Type I Interferon (IFN) and Interferon-Stimulated Gene (ISG) Turnover: Early in infection, IFN signaling induces ISGs to launch an aggressive innate antiviral defense; healthy cells rely on rapid mRNA degradation to deactivate this response before it damages healthy tissues.
  • Species-Dependent mRNA Partitioning: Human innate defense mRNAs possess folding structures that promote trapping and stabilization inside viral condensates, prolonging harmful cytokine production, whereas differently folded bat defense mRNAs largely avoid capture and preserve immune balance.

Branches of Science: Molecular Virology, Immunology, RNA Biology, Structural Biology, and Comparative Immunology.

Future Application: These findings establish a concrete molecular mechanism for researchers to validate across additional human patient specimens and animal samples. Determining the full extent to which species-specific RNA folding accounts for divergent disease outcomes will help investigators further dissect natural viral control in bats and cellular dysfunction in human Ebola infections.

Why It Matters: Identifying why Ebola virus triggers lethal, self-destructive inflammation in humans while sparing bat hosts addresses a central paradox of severe Ebola disease. By showing that host RNA folding dictates whether antiviral defense transcripts become trapped and shielded from degradation inside viral condensates, the study links viral replication compartments directly to runaway cytokine production. Given the approximately 50% human fatality rate of Ebola virus and its relatives, defining these molecular mechanisms is critical for understanding why human immune responses turn deadly.

Ebola virus disease has an average case fatality rate of approximately 50% in humans, although mortality among filoviruses varies widely depending on the viral species and outbreak. According to the US Centers for Disease Control and Prevention, an ongoing outbreak of Ebola disease caused by Bundibugyo virus—a close relative of Ebola virus—that began in the Democratic Republic of the Congo in May 2026 had resulted in 11,613 confirmed cases and 5,678 confirmed deaths in the country as of November 17, 2026.

Although several bat species can harbor filoviruses without developing overt disease, the molecular mechanisms underlying this tolerance—and humans’ contrasting susceptibility to severe illness—remain incompletely understood.

“Another puzzle,” said senior author Erica Ollmann Saphire, a professor at the La Jolla Institute for Immunology (LJI), “is why humans do get so sick. And why the worst cases can have the strongest inflammatory responses. These are strong immune responses, but they’re not working well.”

In a study published in Cell in November 2026, LJI researchers—working in collaboration with Aartjan te Velthuis and Clifford Brangwynne of Princeton University and Gene Yeo of the University of California San Diego—used cultured human and bat cells expressing viral condensate-forming proteins, along with a replication-deficient Ebola virus system, to investigate why humans are particularly vulnerable to severe Ebola virus disease.

The mechanism centers on intracellular compartments that function as viral “nests.” Inside host cells, Ebola virus forms protective, dropletlike compartments without surrounding membranes—technically termed membraneless condensates—where the virus concentrates its messenger RNA (mRNA).

Using multiplexed error-robust fluorescence in situ hybridization (MERFISH)-based subcellular spatial transcriptomics, the researchers found that Ebola virus condensates also sequester host cellular mRNAs. This sequestration appears to impair the human immune system’s ability to regulate inflammation, a disruption that may contribute to the hyperinflammatory cascade, organ failure, and high mortality observed in severe Ebola virus disease.

Homologous mRNA molecules in bat cells adopt different folded secondary structures and are recruited into viral condensates far less frequently. This reduced sequestration may help explain how certain bat species tolerate filovirus infection without developing severe inflammatory disease.

How Ebola Virus Forms Viral Condensates

When Ebola virus enters a human or bat host cell, two viral proteins—nucleoprotein (NP) and viral protein 35 (VP35)—interact with RNA and undergo phase separation from the surrounding cytoplasm to form membraneless viral condensates, also known as viral factories or inclusion bodies, where molecular building blocks for viral progeny are enriched.

“When birds land in a new place, they make nests where they can raise their babies. You can imagine viral condensates as nests for a virus,” said first author Jingru Fang, who conducted the research at LJI and Princeton University.

As Ebola virus assembles these condensates, it also draws in nearby host cellular mRNAs.

Regulation of the Antiviral mRNA Response

Most cellular processes depend on mRNAs, single-stranded molecules that carry genetic instructions from DNA in the cell nucleus to ribosomes, the cellular machinery that translates mRNA sequences into proteins. A single mRNA molecule can serve as the template for many copies of a protein.

In a healthy cell, mRNA molecules are typically degraded after translation is complete. Timely mRNA turnover is especially critical for transcripts encoding immune defense molecules involved in fighting infection.

Early in viral infection, infected cells secrete signaling proteins known as interferons (IFNs)—specifically type I IFNs—to alert neighboring cells to an impending infection. This paracrine signal activates the expression of interferon-stimulated genes (ISGs), whose products establish an antiviral state that restricts viral replication, sometimes at the expense of suppressing normal host cellular functions.

“This is a first line of defense that our bodies can mount,” said Fang. “However, as you can imagine, if this aggressive response is kept up too long, it will cause damage to the host.”

Because the same antiviral response that inhibits viral replication can also damage healthy tissue, ISG expression is tightly restricted to brief windows. Through regulated mRNA degradation, cells curb the antiviral response before widespread tissue damage occurs. “The antiviral response is like a weapon, and cells use degradation as a way to deactivate that weapon,” said Fang.

This regulatory turnover is disrupted when host antiviral mRNAs are sequestered inside viral condensates.

Structural Differences Between Human and Bat mRNAs

Dysregulated, excessive cytokine production—often termed a cytokine storm—is a major driver of tissue damage and mortality in severe Ebola virus disease. “In patients with fatal cases, there tends to be this abnormal upregulation of a certain panel of genes that direct the innate immune response,” said Fang.

In the study, the researchers compared the secondary structures of human and bat mRNAs to examine why specific host transcripts were preferentially recruited into viral condensates. They discovered a two-part structural rule that shifts during an immune response: in unstimulated cells, condensates selectively recruited host mRNAs with minimally folded coding regions via single-stranded RNA binding by NP. After type I IFN stimulation, however, recruitment shifted to the 3′ untranslated region (3′ UTR), concentrating human ISG transcripts that carry tightly folded, highly structured 3′ UTRs—mirroring structural features conserved in the viral RNA genome itself.

Many of the sequestered human transcripts encode regulators and effectors of the type I IFN response, a rapid innate antiviral pathway conserved across mammalian cell types. Expression of these genes is tightly controlled and is normally followed by rapid mRNA degradation to minimize host tissue damage.

Viral condensates shield these sequestered mRNAs from normal cytoplasmic degradation by excluding key RNA-cleanup enzymes such as the exonuclease XRN1. Although these compartments exclude translation machinery such as ribosomes and the initiation factor eIF4G from their interior during early infection, protecting these transcripts from decay prolonged their half-life and amplified—rather than dampened—antiviral gene expression, driving higher levels of both ISG mRNAs and their encoded defense proteins.

“These are potentially harmful kinds of genes,” said Fang. “And now they’re persisting longer than they normally would.”

The researchers also examined mRNAs from kidney cells of the Egyptian fruit bat (Rousettus aegyptiacus), a widely studied fruit bat model and natural reservoir for Marburg virus, a filovirus related to Ebola virus—though not a confirmed natural reservoir for Ebola virus itself. Although these bat cells expressed antiviral mRNAs analogous to human transcripts within the conserved innate immune pathway, the bat ISG transcripts featured less structured, reduced folding in their 3′ UTRs and were recruited into viral condensates far less often.

As a result, Fang said, this structural difference may help explain how Egyptian fruit bats—and potentially other filovirus-tolerant bat species—restrain viral replication while keeping harmful inflammation in check.

“We don’t know whether this difference can explain everything, but it gives researchers a place to start looking and confirm what we’ve found in additional human or animal samples,” said Fang.

Funding: This research received additional support from the Howard Hughes Medical Institute, the Princeton Biomolecular Condensate Program, the Princeton Center for Complex Materials, the U.S. National Science Foundation Materials Research Science and Engineering Centers (NSF DMR-2011750), the St. Jude Collaborative on Membraneless Organelles, the AFOSR Multidisciplinary Research Program of the University Research Initiative (FA9550-20-1-0241), the Chan Zuckerberg Initiative Exploratory Cell Network, the National Institutes of Health (grant DP2 AI17547401), and the UC San Diego Sanford Stem Cell Institute. Fang was also supported by The Tullie and Rickey Families SPARK Awards for Innovations in Immunology, through the generosity of LJI Board Director Sandor Shapery and Rebecca Shapery, and a 2025 Omenn Darling Postdoctoral Fellowship through Princeton Bioengineering Institute.

Published in journal: Cell 

Title: RNA folding drives species-dependent host mRNA partitioning in Ebola virus condensates

Authors: Jingru Fang, Dylan C. Lam, Clarence K. Mah, Reika Watanabe, Hailey M. Tanner, Troy Comi, Yuan Cai, Cheng-Yi Chen, Aartjan J.W. te Velthuis, Clifford P. Brangwynne, Gene W. Yeo, and Erica Ollmann Saphire

Source/Credit: La Jolla Institute for Immunology

Edited by: Scientific Frontline

Reference Number: vi112026_01

Privacy Policy | Terms of Service | Contact Us

Featured Article

What Is: The Minimal Genome and Synthetic Evolution

Scientific Frontline: Extended "At a Glance" Summary : The Minimal Genome and Synthetic Evolution The Core Concept : Researchers h...

Top Viewed Articles